Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety, Tolerability, PK, and PD of HRS-7535 in Healthy Subjects
NCT05347758Phase 1Unknown
- Sponsor
- Shandong Suncadia Medicine Co., Ltd.
- Start
- May 2022
- Primary completion
- Sep 2022
01
Overview
Phase 1, randomised, double-blind trial comparing HRS-7535 with Placebo (2 arms). Status: unknown.
02
Drugs
HRS-7535
Beyond the preview
Go deeper on NCT05347758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05347758.